Covered recipient · General Payments record
SHENGCHANG SU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2024
$924.58
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $924.58 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $244.66 | 2 |
| Medtronic, Inc. | $147.00 | 1 |
| BETA BIONICS, INC. | $142.36 | 1 |
| Insulet Corporation | $124.71 | 1 |
| SANOFI-AVENTIS U.S. LLC | $121.17 | 1 |
| Tandem Diabetes Care, Inc. | $120.78 | 1 |
| Acerta Pharma LLC | $23.90 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $924.58 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $23.90 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104257893 | CMS |
| BETA BIONICS, INC. | $142.36 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087887433 | CMS |
| Insulet Corporation | $124.71 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795873 | CMS |
| Lilly USA, LLC | $125.38 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940184 | CMS |
| Lilly USA, LLC | $119.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135889376 | CMS |
| Medtronic, Inc. | $147.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116997978 | CMS |
| SANOFI-AVENTIS U.S. LLC | $121.17 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140001063 | CMS |
| Tandem Diabetes Care, Inc. | $120.78 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138752441 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.